Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease. A Cross Sectional Study in Norway.
Completed
- Conditions
- Inflammatory Bowel Diseases
- Registration Number
- NCT01524328
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
The purpose of this study is to investigate the proportion of use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD). In addition, the reason for, and satisfaction with use of CAM.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 460
Inclusion Criteria
- Patients >18 years and with verified diagnosis of Crohn's disease or ulcerative colitis attending an outpatient clinic in a Norwegian hospital.
Exclusion Criteria
- Patients <18 years.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie CAM efficacy in inflammatory bowel disease (IBD) as studied in NCT01524328?
How does CAM use in NCT01524328 compare to standard-of-care treatments for Crohn's disease and ulcerative colitis?
Are there specific biomarkers in IBD patients that correlate with CAM treatment satisfaction and outcomes in NCT01524328?
What adverse events are associated with complementary therapies in IBD as reported in NCT01524328?
What combination approaches involving CAM and conventional IBD therapies are being explored in Norwegian clinical research?
Trial Locations
- Locations (1)
Oslo university hospital
🇳🇴Oslo, Norway
Oslo university hospital🇳🇴Oslo, Norway